US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5962219A
(en)
*
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
US5795747A
(en)
*
|
1991-04-16 |
1998-08-18 |
Evotec Biosystems Gmbh |
Process for manufacturing new biopolymers
|
DE4112440C1
(ko)
*
|
1991-04-16 |
1992-10-22 |
Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De |
|
AU2313392A
(en)
*
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
US5783384A
(en)
*
|
1992-01-13 |
1998-07-21 |
President And Fellows Of Harvard College |
Selection of binding-molecules
|
US5643873A
(en)
*
|
1992-05-06 |
1997-07-01 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
|
US5728802A
(en)
*
|
1992-05-06 |
1998-03-17 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
|
US5648458A
(en)
*
|
1992-05-06 |
1997-07-15 |
Affymax Technologies N.V. |
Peptides and compounds that bind to ELAM-1
|
WO1994005812A1
(en)
*
|
1992-09-02 |
1994-03-17 |
The Scripps Research Institute |
Coupled isothermal polynucleotide amplification and translation system
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
AU8124694A
(en)
*
|
1993-10-29 |
1995-05-22 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5525734A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies N.V. |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5525735A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
EP0789783B1
(en)
*
|
1994-09-21 |
2002-05-08 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
WO1996020947A1
(en)
*
|
1994-12-30 |
1996-07-11 |
Chiron Corporation |
Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides
|
US6341256B1
(en)
*
|
1995-03-31 |
2002-01-22 |
Curagen Corporation |
Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
JP2000511050A
(ja)
*
|
1996-05-31 |
2000-08-29 |
メディジーン・アクチェンゲゼルシャフト |
機能性分子表面の生成、スクリーニング、および展開のための新規の合成タンパク質の構造の鋳型
|
US6875620B1
(en)
*
|
1996-10-31 |
2005-04-05 |
Agilent Technologies, Inc. |
Tiling process for constructing a chemical array
|
ATE332368T1
(de)
|
1997-01-21 |
2006-07-15 |
Gen Hospital Corp |
Selektion von proteinen mittels rns-protein fusionen
|
US6261804B1
(en)
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
GB9703369D0
(en)
*
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
GB2338237B
(en)
*
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
WO1998048008A1
(en)
*
|
1997-04-23 |
1998-10-29 |
Plueckthun Andreas |
Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules
|
ES2283936T3
(es)
*
|
1997-07-07 |
2007-11-01 |
Medical Research Council |
Procedimiento de clasificacion in vitro.
|
WO1999005256A2
(en)
*
|
1997-07-24 |
1999-02-04 |
President And Fellows Of Harvard College |
Method for cloning secreted proteins
|
JP4524445B2
(ja)
*
|
1997-09-03 |
2010-08-18 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
タンパク質のスクリーニング方法
|
US6927025B1
(en)
|
1997-09-03 |
2005-08-09 |
Biovation Limited |
Methods for protein screening
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
DE1068357T1
(de)
|
1998-03-30 |
2001-07-19 |
Northwest Biotherapeutics Inc |
Therapeutische und diagnostische anwendungen welche auf der rolle von cxcr-4 in der tumorgenese basieren
|
ATE340870T1
(de)
*
|
1998-04-03 |
2006-10-15 |
Compound Therapeutics Inc |
Adressierbare protein arrays
|
US6440695B1
(en)
*
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
US6562622B1
(en)
*
|
1998-05-08 |
2003-05-13 |
Diatech Pty, Ltd |
Continuous in vitro evolution
|
GB9810756D0
(en)
|
1998-05-19 |
1998-07-15 |
Angeletti P Ist Richerche Bio |
Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
|
EP1092046A4
(en)
*
|
1998-07-02 |
2003-02-19 |
Invitro Diagnostics Inc |
METHODS, COMPOSITIONS AND DEVICE FOR MANUFACTURING NUCLEIC ACIDS HAVING SELECTIVE AFFINITY FOR A TARGET MOLECULE
|
US20040106110A1
(en)
*
|
1998-07-30 |
2004-06-03 |
Solexa, Ltd. |
Preparation of polynucleotide arrays
|
US20030022207A1
(en)
*
|
1998-10-16 |
2003-01-30 |
Solexa, Ltd. |
Arrayed polynucleotides and their use in genome analysis
|
US20100130368A1
(en)
*
|
1998-07-30 |
2010-05-27 |
Shankar Balasubramanian |
Method and system for sequencing polynucleotides
|
US6787308B2
(en)
*
|
1998-07-30 |
2004-09-07 |
Solexa Ltd. |
Arrayed biomolecules and their use in sequencing
|
US20040002101A1
(en)
*
|
1998-08-12 |
2004-01-01 |
Proteus S.A. |
Method and kit for discovering nucleic acids that encode desired functions
|
DK1105360T3
(da)
|
1998-08-17 |
2009-11-02 |
Bristol Myers Squibb Co |
Identifikation af forbindelse-protein-interaktioner ved anvendelse af biblioteker af protein-nukleinsyrefusionsmolekyler
|
EP1105516A4
(en)
*
|
1998-08-17 |
2002-01-09 |
Phylos Inc |
METHODS FOR PRODUCING PRIVATE NUCLEIC ACIDS FROM 3 'NON-TRANSLATED REGIONS AND FOR OPTIMIZING THE FORMATION OF A CELL-PROTEIN RNA FUSION
|
US20060088846A1
(en)
|
1998-08-28 |
2006-04-27 |
Michele Pagano |
Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
|
WO2000032823A1
(en)
|
1998-12-02 |
2000-06-08 |
Phylos, Inc. |
Dna-protein fusions and uses thereof
|
TR200501367T2
(tr)
|
1999-03-25 |
2005-09-21 |
Abbott Gmbh & Co. Kg |
Beşeri IL-12'yi bağlayan beşeri antikorlar ve bunları üretmek için yöntemler.
|
US6914128B1
(en)
*
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
US7883704B2
(en)
*
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
AU5011400A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in t cells
|
WO2000072869A1
(en)
|
1999-06-01 |
2000-12-07 |
Phylos, Inc. |
Methods for producing 5'-nucleic acid-protein conjugates
|
US20030091999A1
(en)
*
|
1999-10-01 |
2003-05-15 |
Zhongping Yu |
Compositions and methods for identifying polypeptides and nucleic acid molecules
|
US7022479B2
(en)
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
ATE322558T1
(de)
|
2000-01-24 |
2006-04-15 |
Compound Therapeutics Inc |
Sensible und multiplexe diagnostische tests zur proteinanalyse
|
ATE311444T1
(de)
*
|
2000-03-31 |
2005-12-15 |
Cambridge Antibody Tech |
Verbesserungen in bezug auf ribosom-komplexe als selektionspartikel
|
CA2405709A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
EP2184291A1
(en)
|
2000-08-18 |
2010-05-12 |
Dyax Corp. |
Binding polypeptides for B lymphocyte stimulator protein (BLyS)
|
WO2002020565A2
(en)
|
2000-09-08 |
2002-03-14 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
JP4723713B2
(ja)
*
|
2000-09-25 |
2011-07-13 |
トヨタ自動車株式会社 |
mRNAの潜在的翻訳制御因子のスクリーニング方法
|
US20040091509A1
(en)
*
|
2000-12-14 |
2004-05-13 |
Avon Products, Inc. |
Skin care composition that mediates cell to cell communication
|
KR100401296B1
(ko)
*
|
2000-12-27 |
2003-10-11 |
드림바이오젠 주식회사 |
수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
|
JP4061043B2
(ja)
|
2000-12-28 |
2008-03-12 |
株式会社ポストゲノム研究所 |
invitro転写/翻訳系によるペプチド等の製造方法
|
ES2271306T5
(es)
|
2001-03-19 |
2013-10-16 |
President And Fellows Of Harvard College |
Evolución de una nueva función molecular
|
EP1249499A1
(de)
*
|
2001-04-10 |
2002-10-16 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren und Vorrichtung zur Bestimmung und Selektion von Molekül-Molekül-Wechselwirkungen
|
KR20030093316A
(ko)
|
2001-04-13 |
2003-12-06 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
혈관 내피 성장 인자 2
|
NZ530098A
(en)
|
2001-06-20 |
2006-02-24 |
Nuevolution As |
Templated molecules and methods for using such molecules
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
GB0115841D0
(en)
|
2001-06-28 |
2001-08-22 |
Medical Res Council |
Ligand
|
EP1440083B1
(en)
|
2001-10-25 |
2013-01-02 |
Medical Research Council |
Molecules
|
GB0126887D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Univ London |
Method for producing and identifying soluble protein domains
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
JP2005512578A
(ja)
*
|
2001-12-19 |
2005-05-12 |
ロシュ ダイアグノスティックス コーポレーション |
Pcrをベースとする高効率のポリペプチドスクリーニング
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20030166282A1
(en)
*
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP2213292B2
(en)
|
2002-02-01 |
2016-06-22 |
Life Technologies Corporation |
Double-stranded oligonucleotides
|
AU2003217716A1
(en)
*
|
2002-02-25 |
2003-09-09 |
Cabot Corporation |
Custom ligand design for biomolecular filtration and purification for bioseperation
|
DK1487978T3
(da)
|
2002-03-15 |
2009-03-23 |
Nuevolution As |
Forbedret fremgangsmåde til syntese af templatemolekyler
|
EP1572927A4
(en)
|
2002-04-08 |
2007-10-17 |
Pioneer Hi Bred Int |
REINFORCED EXTRACTION OF SILK UNDER STRESS
|
WO2003095611A2
(en)
|
2002-05-10 |
2003-11-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Androgen-regulated pmepa1 and cancer
|
US20040033602A1
(en)
*
|
2002-06-12 |
2004-02-19 |
Ambion, Inc. |
Methods and compositions relating to polypeptides with RNase III domains that mediate RNA interference
|
US20100075423A1
(en)
*
|
2002-06-12 |
2010-03-25 |
Life Technologies Corporation |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US20060002935A1
(en)
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
EP1539980B1
(en)
|
2002-08-01 |
2016-02-17 |
Nuevolution A/S |
Library of complexes comprising small non-peptide molecules and double-stranded oligonucleotides identifying the molecules
|
JP4657919B2
(ja)
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
WO2004022746A1
(en)
|
2002-09-06 |
2004-03-18 |
Isogenica Limited |
In vitro peptide expression libraray
|
CA2495449A1
(en)
|
2002-09-09 |
2004-03-18 |
Arbor Vita Corporation |
Methods of diagnosing cervical cancer
|
EP1545762A2
(en)
|
2002-09-27 |
2005-06-29 |
Carlsberg A/S |
Spatially encoded polymer matrix
|
EP1558744B1
(en)
|
2002-10-30 |
2011-06-15 |
Nuevolution A/S |
Enzymatic encoding
|
WO2004041213A2
(en)
*
|
2002-11-04 |
2004-05-21 |
Bioarctic Neuroscience Ab |
Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
|
EP1563067A4
(en)
*
|
2002-11-04 |
2006-06-07 |
Icogenex Corp |
METHODS OF IDENTIFYING AGENTS MODULATING THE STRUCTURE AND MOLECULAR MATURATION OF A MEMBRANE PRECURSOR PROTEIN
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
WO2004056994A2
(en)
|
2002-12-19 |
2004-07-08 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
EP2058275A1
(en)
*
|
2003-01-07 |
2009-05-13 |
Ramot at Tel-Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
JP4480715B2
(ja)
|
2003-01-29 |
2010-06-16 |
454 コーポレーション |
二重末端シーケンシング
|
WO2004074429A2
(en)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Method for producing second-generation library
|
US10533998B2
(en)
|
2008-07-18 |
2020-01-14 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
WO2004083427A2
(en)
|
2003-03-20 |
2004-09-30 |
Nuevolution A/S |
Ligational encoding of small molecules
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
EP2532745B1
(en)
|
2003-07-05 |
2015-09-09 |
The Johns Hopkins University |
Method and Compositions for Detection and Enumeration of Genetic Variations
|
US7585815B2
(en)
*
|
2003-07-24 |
2009-09-08 |
Lawrence Livermore National Security, Llc |
High throughput protein production screening
|
WO2005023993A2
(en)
|
2003-09-09 |
2005-03-17 |
Integrigen, Inc. |
Methods and compositions for generation of germline human antibody genes
|
US11118215B2
(en)
|
2003-09-18 |
2021-09-14 |
Nuevolution A/S |
Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
JP4917889B2
(ja)
*
|
2003-09-25 |
2012-04-18 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を処置するための組成物及びその使用方法
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
EP2366705A1
(en)
|
2003-12-17 |
2011-09-21 |
Praecis Pharmaceuticals Incorporated |
Methods for synthesis of encoded libraries
|
US7972994B2
(en)
|
2003-12-17 |
2011-07-05 |
Glaxosmithkline Llc |
Methods for synthesis of encoded libraries
|
US20080119412A1
(en)
|
2003-12-23 |
2008-05-22 |
Nono Inc. |
Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins
|
EP1730277B1
(en)
|
2004-03-22 |
2009-10-28 |
Nuevolution A/S |
Ligational encoding using building block oligonucleotides
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
DE602005025106D1
(de)
|
2004-05-11 |
2011-01-13 |
Axiogenesis Ag |
Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP1781310B1
(en)
|
2004-08-02 |
2015-10-14 |
Ramot at Tel Aviv University Ltd. |
Articles of peptide nanostructures and method of forming the same
|
ATE539745T1
(de)
|
2004-08-19 |
2012-01-15 |
Univ Tel Aviv Future Tech Dev |
Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
|
TWI374935B
(en)
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
US7300773B2
(en)
*
|
2004-08-27 |
2007-11-27 |
Wyeth Research Ireland Limited |
Production of TNFR-Ig
|
US7786086B2
(en)
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
KR20070084069A
(ko)
|
2004-10-08 |
2007-08-24 |
도만티스 리미티드 |
Tnfr1에 대한 단일 도메인 항체 및 이의 사용 방법
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
KR100730875B1
(ko)
|
2004-12-07 |
2007-06-20 |
가부시키가이샤 시마즈세이사쿠쇼 |
번역반응 촉진 dna 단편 및 그것을 사용한 무세포계단백질 합성방법
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
JP2008532559A
(ja)
|
2005-03-19 |
2008-08-21 |
メディカル リサーチ カウンシル |
ウイルス感染の治療及び予防又は治療及び予防の改善
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
WO2006123445A1
(ja)
*
|
2005-05-18 |
2006-11-23 |
Kyoto University |
タンパク質の表示方法
|
WO2007005955A2
(en)
|
2005-06-30 |
2007-01-11 |
Centocor, Inc. |
Anti-il-23 antibodies, compositions, methods and uses
|
CA2617539A1
(en)
|
2005-07-01 |
2007-01-11 |
Washington University In St. Louis |
Phosphospecific chemokine receptor antibodies
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
US20070111237A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Maurizio Zanetti |
Process for identifying antigenized antibodies using ribosome cell free expression system
|
EP1973928A2
(en)
*
|
2005-10-11 |
2008-10-01 |
Ramot at Tel-Aviv University Ltd. |
Self-assembled fmoc-ff hydrogels
|
EP2368868A1
(en)
|
2005-10-28 |
2011-09-28 |
Praecis Pharmaceuticals Inc. |
Methods for identifying compounds of interest using encoded libraries
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
LT3018206T
(lt)
|
2005-12-01 |
2021-12-10 |
Nuevolution A/S |
Fermentiniai kodavimo būdai, skirti didelių bibliotekų efektyviai sintezei
|
EA035459B1
(ru)
|
2005-12-29 |
2020-06-19 |
Сентокор, Инк. |
Антитело против il-23p19
|
EP1984738A2
(en)
|
2006-01-11 |
2008-10-29 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use in the formation and control of nanoreactors
|
EP2010569A4
(en)
|
2006-03-20 |
2009-09-09 |
Xoma Technology Ltd |
FOR GASTRIN SPECIFIC HUMAN ANTIBODIES, MATERIALS AND METHODS
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP2530167A1
(en)
|
2006-05-11 |
2012-12-05 |
Raindance Technologies, Inc. |
Microfluidic Devices
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
WO2008005290A2
(en)
|
2006-06-29 |
2008-01-10 |
The Trustees Of Columbia University In The City Of New York |
Methods for testing anti-thrombotic agents
|
JP5746468B2
(ja)
|
2006-07-11 |
2015-07-08 |
ノノ インコーポレイテッド |
発熱を伴う脳卒中を処置する方法および組成物
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
WO2008060448A2
(en)
|
2006-11-10 |
2008-05-22 |
Massachusetts Institute Of Technology |
Small molecule pak inhibitors
|
EP2094306A2
(en)
|
2006-12-20 |
2009-09-02 |
XOMA Technology Ltd. |
Treatment of il-1-beta related diseases
|
AU2008205512B2
(en)
|
2007-01-16 |
2014-06-12 |
Abbvie Inc. |
Methods for treating psoriasis
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
RU2476442C2
(ru)
|
2007-03-29 |
2013-02-27 |
Эббот Лэборетриз |
Кристаллические антитела против il-12 человека
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
WO2009015063A2
(en)
|
2007-07-23 |
2009-01-29 |
Centocor |
Methods and compositions for treating fibrosis related disorders using il-17 antagonists
|
US7678883B2
(en)
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
CA2706439C
(en)
|
2007-11-20 |
2015-04-21 |
Pioneer Hi-Bred International, Inc. |
Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants
|
CA2710252C
(en)
|
2007-12-20 |
2017-03-28 |
Xoma Technology Ltd. |
Methods for the treatment of gout
|
AU2009225797A1
(en)
|
2008-03-18 |
2009-09-24 |
Abbvie Inc. |
Methods for treating psoriasis
|
GB0806562D0
(en)
|
2008-04-10 |
2008-05-14 |
Fermentas Uab |
Production of nucleic acid
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
EP2315629B1
(en)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Droplet libraries
|
WO2010011944A2
(en)
*
|
2008-07-25 |
2010-01-28 |
Wagner Richard W |
Protein screeing methods
|
CA2733642A1
(en)
|
2008-08-14 |
2010-02-18 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
EP2356231A2
(en)
*
|
2008-09-26 |
2011-08-17 |
Wyeth LLC |
Compatible display vector systems
|
WO2010036856A2
(en)
|
2008-09-26 |
2010-04-01 |
Wyeth Llc |
Compatible display vector systems
|
KR101781907B1
(ko)
|
2008-10-31 |
2017-09-26 |
얀센 바이오테크 인코포레이티드 |
파이브로넥틴 타입 ⅲ 도메인 기반 스캐폴드 조성물, 방법 및 용도
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
NZ606283A
(en)
*
|
2008-11-28 |
2014-08-29 |
Abbvie Inc |
Stable antibody compositions and methods for stabilizing same
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158822A1
(en)
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
EP2379076B1
(en)
|
2008-12-23 |
2014-11-12 |
The Trustees of Columbia University in the City of New York |
Phosphodiesterase inhibitors and uses thereof
|
WO2010074783A1
(en)
|
2008-12-23 |
2010-07-01 |
The Trustees Of Columbia University In The City Of New York |
Phosphodiesterase inhibitors and uses thereof
|
EP2396011B1
(en)
|
2009-02-12 |
2016-04-13 |
Janssen Biotech, Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
US8716553B2
(en)
|
2009-03-02 |
2014-05-06 |
Pioneer Hi Bred International Inc |
NAC transcriptional activators involved in abiotic stress tolerance
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
US20100247590A1
(en)
*
|
2009-03-30 |
2010-09-30 |
Johnson & Johnson |
Peptide-Based Systems For Delivery Of Cosmetic Agents
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
US20110035843A1
(en)
|
2009-08-05 |
2011-02-10 |
Pioneer Hi-Bred International, Inc. |
Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
|
KR101161622B1
(ko)
*
|
2009-08-31 |
2012-07-04 |
헬릭스 주식회사 |
번역 효율 증진용 dna 단편 및 이를 포함하는 재조합 벡터
|
AU2010291927A1
(en)
*
|
2009-09-14 |
2012-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Methods for treating psoriasis
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
EP3187877A1
(en)
|
2009-09-25 |
2017-07-05 |
XOMA Technology Ltd. |
Screening methods
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
DK2488867T3
(da)
|
2009-10-14 |
2020-11-09 |
Janssen Biotech Inc |
Fremgangsmåder til affinitetsmodning af antistoffer
|
US20110165648A1
(en)
|
2009-11-04 |
2011-07-07 |
Menno Van Lookeren Campagne |
Co-crystal structure of factor D and anti-factor D antibody
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
US10640457B2
(en)
|
2009-12-10 |
2020-05-05 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
EP2509590B1
(en)
|
2009-12-10 |
2019-10-30 |
The Trustees of Columbia University in the City of New York |
Histone acetyltransferase activators and uses thereof
|
WO2011079176A2
(en)
|
2009-12-23 |
2011-06-30 |
Raindance Technologies, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
MX341687B
(es)
|
2010-02-10 |
2016-08-30 |
Immunogen Inc |
"anticuerpos cd20 y su utilización".
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
EP2534267B1
(en)
|
2010-02-12 |
2018-04-11 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
WO2011111832A1
(ja)
|
2010-03-11 |
2011-09-15 |
独立行政法人理化学研究所 |
ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用
|
SI2558577T1
(sl)
|
2010-04-16 |
2019-05-31 |
Nuevolution A/S |
Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
|
KR101863033B1
(ko)
|
2010-04-30 |
2018-06-01 |
얀센 바이오테크 인코포레이티드 |
안정화된 파이브로넥틴 도메인 조성물, 방법 및 용도
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
EP2606119A1
(en)
|
2010-08-20 |
2013-06-26 |
Wyeth LLC |
Cell culture of growth factor-free adapted cells
|
EP2614073B1
(en)
|
2010-09-07 |
2018-03-14 |
Technische Universität München |
Recombinant bacterial lipocalin blc and uses thereof
|
EP3447155A1
(en)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
PL2635299T3
(pl)
|
2010-11-02 |
2020-03-31 |
The Trustees Of Columbia University In The City Of New York |
Sposoby leczenia zaburzeń utraty włosów
|
JP6616057B2
(ja)
|
2010-12-22 |
2019-12-04 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
ヒストンアセチル基転移酵素モジュレーターおよびその使用
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
EP3859011A1
(en)
|
2011-02-11 |
2021-08-04 |
Bio-Rad Laboratories, Inc. |
Methods for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
JP5948673B2
(ja)
|
2011-03-10 |
2016-07-06 |
ジーンフロンティア株式会社 |
リポ多糖混入量を低減した蛋白質合成用組成物、該組成物を用いた蛋白質製造方法
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
US20120301904A1
(en)
*
|
2011-04-26 |
2012-11-29 |
Prosetta Antiviral, Inc |
Multiprotein assemblies
|
US9863936B2
(en)
|
2011-05-23 |
2018-01-09 |
Riken |
Nucleic acid construct, nucleic acid-protein complex, and use thereof
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
KR102577578B1
(ko)
|
2011-06-03 |
2023-09-11 |
조마 테크놀로지 리미티드 |
Tgf-베타에 특이적인 항체
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
BR112014005104A2
(pt)
|
2011-09-02 |
2017-07-04 |
Salk Inst For Biological Studi |
inibidores camkii, ip3r, calcineurin, p38 e mk2/3 para tratar atar distúrbios metabólicos de obesidade
|
EP2758433B1
(en)
|
2011-09-19 |
2017-10-18 |
Axon Neuroscience SE |
Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
|
EP4151785A1
(en)
|
2011-09-27 |
2023-03-22 |
Janssen Biotech, Inc. |
Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces
|
WO2013057628A1
(en)
|
2011-10-21 |
2013-04-25 |
Pfizer Inc. |
Addition of iron to improve cell culture
|
CA2853449A1
(en)
|
2011-10-25 |
2013-05-02 |
Pioneer Hi-Bred International, Inc. |
Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
|
EP2794657B1
(en)
|
2011-12-19 |
2017-10-11 |
Xoma (Us) Llc |
Methods for treating acne
|
HUE040127T2
(hu)
|
2012-03-29 |
2019-02-28 |
Univ Columbia |
Eljárások hajhullási rendellenességek kezelésére
|
AU2013243951A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
EP2657334B1
(en)
|
2012-04-26 |
2016-07-06 |
GeneFrontier Corporation |
Efficient method for displaying protein multimer
|
ES2755104T3
(es)
|
2012-05-17 |
2020-04-21 |
Ra Pharmaceuticals Inc |
Inhibidores peptídicos y peptidomiméticos
|
GB201214029D0
(en)
*
|
2012-08-07 |
2012-09-19 |
Queen Mary & Westfield College |
method
|
US9695228B2
(en)
|
2012-11-21 |
2017-07-04 |
Janssen Biotech, Inc. |
EGFR and c-Met fibronectin type III domain binding molecules
|
US9593164B2
(en)
|
2012-11-21 |
2017-03-14 |
Janssen Biotech, Inc. |
Bispecific EGFR/c-Met antibodies
|
EP3578663A1
(en)
*
|
2013-03-15 |
2019-12-11 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
WO2014152507A2
(en)
|
2013-03-15 |
2014-09-25 |
Pioneer Hi-Bred International, Inc. |
Modulation of acc deaminase expression
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
WO2014152030A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Removal of dna fragments in mrna production process
|
EP2971161B1
(en)
|
2013-03-15 |
2018-12-26 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
EP3971287A1
(en)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
US10385088B2
(en)
|
2013-10-02 |
2019-08-20 |
Modernatx, Inc. |
Polynucleotide molecules and uses thereof
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
KR102478402B1
(ko)
|
2013-10-14 |
2022-12-15 |
얀센 바이오테크 인코포레이티드 |
시스테인 조작된 피브로넥틴 iii형 도메인 결합 분자
|
US9309314B2
(en)
|
2013-12-03 |
2016-04-12 |
Agency For Science, Technology And Research (A*Star) |
Polypeptides, nucleic acids and uses thereof
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
ES2920677T3
(es)
|
2013-12-24 |
2022-08-08 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-VISTA
|
EP3090063B1
(en)
|
2013-12-31 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Method for detection of latent retrovirus
|
EP3119876A1
(en)
|
2014-03-19 |
2017-01-25 |
Pfizer Inc. |
Method of cell culture
|
KR102503319B1
(ko)
|
2014-06-12 |
2023-02-28 |
라 파마슈티컬스 인코포레이티드 |
보체 활성의 조절
|
US10286086B2
(en)
|
2014-06-19 |
2019-05-14 |
Modernatx, Inc. |
Alternative nucleic acid molecules and uses thereof
|
CN114057857A
(zh)
|
2014-06-20 |
2022-02-18 |
豪夫迈·罗氏有限公司 |
基于chagasin的支架组合物、方法和应用
|
WO2016011222A2
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
ES2900998T3
(es)
|
2015-01-28 |
2022-03-21 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento
|
EP3265491A1
(en)
|
2015-03-03 |
2018-01-10 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
CN108136001B
(zh)
|
2015-04-03 |
2022-07-29 |
佐马技术有限公司 |
使用TGF-β抑制剂和PD-1抑制剂治疗癌症
|
WO2016172485A2
(en)
|
2015-04-24 |
2016-10-27 |
Genentech, Inc. |
Multispecific antigen-binding proteins
|
CN107849116A
(zh)
|
2015-05-06 |
2018-03-27 |
詹森生物科技公司 |
前列腺特异性膜抗原结合iii型纤连蛋白结构域
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
JP2018532693A
(ja)
|
2015-08-06 |
2018-11-08 |
ゾーマ (ユーエス) リミテッド ライアビリティ カンパニー |
インスリン受容体に対する抗体断片及び低血糖を治療するためのその使用
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US11434486B2
(en)
|
2015-09-17 |
2022-09-06 |
Modernatx, Inc. |
Polynucleotides containing a morpholino linker
|
CA3214798A1
(en)
|
2015-09-23 |
2017-03-30 |
Pfizer Inc. |
Cells and method of cell culture
|
EP3389692B1
(en)
|
2015-12-16 |
2020-03-04 |
RA Pharmaceuticals, Inc. |
Modulators of complement activity
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
BR112018069776A2
(pt)
|
2016-03-29 |
2019-02-05 |
Janssen Biotech Inc |
tratamento de psoríase com intervalo de dosagem aumentado de anticorpos anti-il-12 e/ou anti-il-23
|
US20190112572A1
(en)
|
2016-04-05 |
2019-04-18 |
Pfizer Inc. |
Cell culture process
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EA201892796A1
(ru)
*
|
2016-06-03 |
2019-06-28 |
Янссен Байотек, Инк. |
Связывающиеся с сывороточным альбумином домены фибронектина типа iii
|
CN109689080A
(zh)
|
2016-06-21 |
2019-04-26 |
詹森生物科技公司 |
半胱氨酸工程化iii型纤连蛋白结构域结合分子
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
EP3475446A1
(en)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
CN109715670A
(zh)
|
2016-07-15 |
2019-05-03 |
波赛达治疗公司 |
对muc1特异性的嵌合抗原受体(car)及其使用方法
|
WO2018014038A1
(en)
|
2016-07-15 |
2018-01-18 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors and methods for use
|
WO2018026748A1
(en)
|
2016-08-01 |
2018-02-08 |
Xoma (Us) Llc |
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof
|
CN109715199A
(zh)
|
2016-09-14 |
2019-05-03 |
詹森生物科技公司 |
包含bcma特异性iii型纤连蛋白结构域的嵌合抗原受体及其用途
|
CN110087681A
(zh)
|
2016-09-28 |
2019-08-02 |
佐马美国有限公司 |
结合白细胞介素-2的抗体和其用途
|
KR20190059305A
(ko)
|
2016-09-30 |
2019-05-30 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
|
AU2017362222A1
(en)
|
2016-11-16 |
2019-05-30 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-IL-23 specific antibody
|
CA3045114A1
(en)
|
2016-12-07 |
2018-06-14 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
WO2018111978A1
(en)
|
2016-12-14 |
2018-06-21 |
Janssen Biotech, Inc. |
Cd137 binding fibronectin type iii domains
|
CN110225770B
(zh)
|
2016-12-14 |
2022-04-26 |
杨森生物科技公司 |
结合cd8a的纤连蛋白iii型结构域
|
US10597438B2
(en)
|
2016-12-14 |
2020-03-24 |
Janssen Biotech, Inc. |
PD-L1 binding fibronectin type III domains
|
EP3354736B1
(en)
*
|
2017-01-25 |
2020-07-01 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Promoter construct for cell-free protein synthesis
|
CN110234351A
(zh)
|
2017-01-30 |
2019-09-13 |
詹森生物科技公司 |
用于治疗活动性银屑病关节炎的抗tnf抗体、组合物和方法
|
JP2020506947A
(ja)
|
2017-02-07 |
2020-03-05 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
KR20190124304A
(ko)
|
2017-03-13 |
2019-11-04 |
포세이다 테라퓨틱스, 인크. |
조혈 줄기세포의 선택적 제거 및 대체를 위한 조성물 및 방법
|
CA3056182A1
(en)
|
2017-03-16 |
2018-09-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
JP2020532987A
(ja)
|
2017-09-08 |
2020-11-19 |
ポセイダ セラピューティクス,インコーポレイティド |
キメラリガンド受容体(clr)介在性の条件遺伝子発現のための組成物および方法
|
KR20200047702A
(ko)
|
2017-09-15 |
2020-05-07 |
브리스톨-마이어스 스큅 컴퍼니 |
관심 폴리펩티드 대규모 생산 동안의 온라인 바이오매스 정전용량 모니터링
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
MX2020009265A
(es)
|
2018-03-05 |
2020-10-01 |
Janssen Biotech Inc |
Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23.
|
KR20200133240A
(ko)
|
2018-03-16 |
2020-11-26 |
브리스톨-마이어스 스큅 컴퍼니 |
단백질 생산 동안의 대사 효소 활성 및 디술피드 결합 환원
|
EP3790587A4
(en)
|
2018-05-11 |
2022-01-26 |
Janssen Biotech, Inc. |
METHOD OF TREATMENT OF DEPRESSION USING IL-23 ANTIBODIES
|
JP2021530697A
(ja)
|
2018-07-18 |
2021-11-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で治療した後の持続応答予測因子
|
CA3160103A1
(en)
|
2018-09-24 |
2020-04-02 |
Janssen Biotech, Inc. |
Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody
|
AU2019383017A1
(en)
|
2018-11-20 |
2021-06-03 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
|
EP3891292A1
(en)
|
2018-12-06 |
2021-10-13 |
Pfizer Inc. |
Cells with reduced inhibitor production and methods of use thereof
|
EP3897722A4
(en)
|
2018-12-18 |
2022-09-14 |
Janssen Biotech, Inc. |
SAFE AND EFFECTIVE METHOD OF TREATING LUPUS WITH AN ANTI-IL12/IL23 ANTIBODY
|
US20220042038A1
(en)
|
2018-12-20 |
2022-02-10 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
CA3126654A1
(en)
|
2019-01-15 |
2020-07-23 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
MX2021008871A
(es)
|
2019-01-23 |
2021-08-19 |
Janssen Biotech Inc |
Composiciones de anticuerpos anti-tnf para usarse en metodos para el tratamiento de la artritis psoriasica.
|
WO2020159445A1
(en)
|
2019-01-31 |
2020-08-06 |
Agency For Science, Technology And Research |
Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
|
US20220153829A1
(en)
|
2019-03-14 |
2022-05-19 |
Janssen Biotech, Inc. |
Methods for Producing Anti-TNF Antibody Compositions
|
CA3133395A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
JP2022525179A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を産生するための産生方法
|
EP3938391A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
CN113853385A
(zh)
|
2019-03-18 |
2021-12-28 |
詹森生物科技公司 |
用抗il12/il23抗体治疗儿科受试者的银屑病的方法
|
JP7397884B2
(ja)
|
2019-05-09 |
2023-12-13 |
ジェネンテック, インコーポレイテッド |
抗体の作製方法
|
BR112021023295A2
(pt)
|
2019-05-23 |
2022-02-08 |
Janssen Biotech Inc |
Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa
|
WO2020245676A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
|
KR20220030952A
(ko)
|
2019-06-03 |
2022-03-11 |
얀센 바이오테크 인코포레이티드 |
활성 강직성 척추염의 치료를 위한 항-tnf 항체, 조성물, 및 방법
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
KR20220057596A
(ko)
|
2019-09-05 |
2022-05-09 |
포세이다 테라퓨틱스, 인크. |
동종이계 세포 조성물 및 사용 방법
|
US11781138B2
(en)
|
2019-10-14 |
2023-10-10 |
Aro Biotherapeutics Company |
FN3 domain-siRNA conjugates and uses thereof
|
CN114786682A
(zh)
|
2019-10-14 |
2022-07-22 |
Aro生物疗法公司 |
结合cd71的纤维粘连蛋白iii型结构域
|
WO2021127505A1
(en)
|
2019-12-20 |
2021-06-24 |
Poseida Therapeutics, Inc. |
Anti-muc1 compositions and methods of use
|
EP4118107A1
(en)
|
2020-03-11 |
2023-01-18 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
CA3174777A1
(en)
|
2020-04-14 |
2021-10-21 |
Eric M. Ostertag |
Compositions and methods for use in the treatment of cancer
|
WO2022087148A1
(en)
|
2020-10-21 |
2022-04-28 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
JP2024510588A
(ja)
|
2021-03-12 |
2024-03-08 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体による、tnf療法に対する不十分な応答を有する乾癬性関節炎患者を治療する方法
|
US20220298236A1
(en)
|
2021-03-12 |
2022-09-22 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
|
CN117957251A
(zh)
|
2021-07-09 |
2024-04-30 |
詹森生物科技公司 |
用于制备抗tnf抗体组合物的制造方法
|
US20230040065A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
WO2023281466A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
AU2022360244A1
(en)
|
2021-10-04 |
2024-04-11 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023079058A1
(en)
|
2021-11-05 |
2023-05-11 |
Yokogawa Insilico Biotechnology Gmbh |
Cell culture with reduced production of lactate
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
WO2023095000A1
(en)
|
2021-11-23 |
2023-06-01 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|
US20240199734A1
(en)
|
2022-11-22 |
2024-06-20 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|